221 related articles for article (PubMed ID: 20158394)
1. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.
Oggè G; Romero R; Kusanovic JP; Chaiworapongsa T; Dong Z; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gonzalez JM; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):820-7. PubMed ID: 20158394
[TBL] [Abstract][Full Text] [Related]
2. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.
Chaiworapongsa T; Romero R; Savasan ZA; Kusanovic JP; Ogge G; Soto E; Dong Z; Tarca A; Gaurav B; Hassan SS
J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1187-207. PubMed ID: 21827221
[TBL] [Abstract][Full Text] [Related]
3. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
Chaiworapongsa T; Romero R; Korzeniewski SJ; Cortez JM; Pappas A; Tarca AL; Chaemsaithong P; Dong Z; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2014 Jan; 27(2):132-44. PubMed ID: 23687930
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.
Kusanovic JP; Romero R; Chaiworapongsa T; Erez O; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gotsch F; Edwin SS; Gomez R; Yeo L; Conde-Agudelo A; Hassan SS
J Matern Fetal Neonatal Med; 2009 Nov; 22(11):1021-38. PubMed ID: 19900040
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
Chaiworapongsa T; Romero R; Korzeniewski SJ; Kusanovic JP; Soto E; Lam J; Dong Z; Than NG; Yeo L; Hernandez-Andrade E; Conde-Agudelo A; Hassan SS
Am J Obstet Gynecol; 2013 Apr; 208(4):287.e1-287.e15. PubMed ID: 23333542
[TBL] [Abstract][Full Text] [Related]
7. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
[TBL] [Abstract][Full Text] [Related]
8. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
[TBL] [Abstract][Full Text] [Related]
9. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
[TBL] [Abstract][Full Text] [Related]
10. Circulating angiogenic and antiangiogenic factors in women with eclampsia.
Vaisbuch E; Whitty JE; Hassan SS; Romero R; Kusanovic JP; Cotton DB; Sorokin Y; Karumanchi SA
Am J Obstet Gynecol; 2011 Feb; 204(2):152.e1-9. PubMed ID: 21062661
[TBL] [Abstract][Full Text] [Related]
11. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
[TBL] [Abstract][Full Text] [Related]
12. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
14. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
[TBL] [Abstract][Full Text] [Related]
15. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
[TBL] [Abstract][Full Text] [Related]
16. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
17. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
Rana S; Cerdeira AS; Wenger J; Salahuddin S; Lim KH; Ralston SJ; Thadhani RI; Karumanchi SA
PLoS One; 2012; 7(10):e48259. PubMed ID: 23110221
[TBL] [Abstract][Full Text] [Related]
19. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
Myatt L; Clifton RG; Roberts JM; Spong CY; Wapner RJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Sciscione A; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
BJOG; 2013 Sep; 120(10):1183-91. PubMed ID: 23331974
[TBL] [Abstract][Full Text] [Related]
20. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
